Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis

Antimicrob Agents Chemother. 2005 Feb;49(2):497-502. doi: 10.1128/AAC.49.2.497-502.2005.

Abstract

Using a murine model of disseminated infection caused by Trichosporon asahii, we have evaluated the efficacies of amphotericin B (AMB; 1 mg/kg of body weight/day), fluconazole (FLC; 20 mg/kg/twice a day), and micafungin (MFG; 5 mg/kg/twice a day). We tested these drugs alone and in combination (MFG with AMB and MFG with FLC). MFG with AMB showed a synergistic effect and demonstrated a higher degree of efficacy in prolonging survival and reducing the kidney fungal burden than either agent alone. The combination MFG with FLC was able to reduce significantly the kidney fungal burden in comparison to that achieved with either drug administered alone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / therapeutic use
  • Animals
  • Antifungal Agents / therapeutic use*
  • Colony Count, Microbial
  • Cyclophosphamide / pharmacology
  • Drug Therapy, Combination
  • Echinocandins
  • Fluconazole / therapeutic use
  • Immunosuppressive Agents / pharmacology
  • Kidney / microbiology
  • Lipopeptides
  • Lipoproteins / therapeutic use*
  • Male
  • Micafungin
  • Mice
  • Mycoses / drug therapy*
  • Peptides, Cyclic / therapeutic use*
  • Trichosporon*

Substances

  • Antifungal Agents
  • Echinocandins
  • Immunosuppressive Agents
  • Lipopeptides
  • Lipoproteins
  • Peptides, Cyclic
  • Amphotericin B
  • Cyclophosphamide
  • Fluconazole
  • Micafungin